SEC Form 4 · Updated Daily
ALRN
Insider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| NOVARTIS AG | 10%+ Owner | 2,079,394 | 2019-04-01 | S |
| Novartis Bioventures Ltd | 10%+ Owner | 2,079,394 | 2019-04-01 | S |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2019-04-01 | NOVARTIS AG | Open-market sale | 20,610 | $1.90 | 2,079,394 |
| 2019-04-01 | Novartis Bioventures Ltd | Open-market sale | 20,610 | $1.90 | 2,079,394 |
| 2019-03-29 | NOVARTIS AG | Open-market sale | 106,540 | $1.85 | 2,100,004 |
| 2019-03-29 | Novartis Bioventures Ltd | Open-market sale | 106,540 | $1.85 | 2,100,004 |
| 2019-03-15 | NOVARTIS AG | Open-market sale | 43,800 | $1.92 | 2,206,544 |
| 2019-03-15 | Novartis Bioventures Ltd | Open-market sale | 43,800 | $1.92 | 2,206,544 |
| 2019-03-14 | NOVARTIS AG | Open-market sale | 13,800 | $1.88 | 2,250,344 |
| 2019-03-14 | Novartis Bioventures Ltd | Open-market sale | 13,800 | $1.88 | 2,250,344 |
| 2019-03-13 | NOVARTIS AG | Open-market sale | 132,738 | $2.12 | 2,264,144 |
| 2019-03-13 | Novartis Bioventures Ltd | Open-market sale | 132,738 | $2.12 | 2,264,144 |
| 2018-08-20 | NOVARTIS AG | Open-market sale | 20,388 | $2.30 | 2,396,882 |
| 2018-08-20 | Novartis Bioventures Ltd | Open-market sale | 20,388 | $2.30 | 2,396,882 |
| 2018-08-17 | NOVARTIS AG | Open-market sale | 8,700 | $2.10 | 2,417,270 |
| 2018-08-17 | Novartis Bioventures Ltd | Open-market sale | 8,700 | $2.10 | 2,417,270 |
| 2018-08-16 | NOVARTIS AG | Open-market sale | 8,808 | $2.10 | 2,425,970 |
| 2018-08-16 | Novartis Bioventures Ltd | Open-market sale | 8,808 | $2.10 | 2,425,970 |
| 2018-08-15 | NOVARTIS AG | Open-market sale | 2,635 | $2.15 | 2,434,778 |
| 2018-08-15 | Novartis Bioventures Ltd | Open-market sale | 2,635 | $2.15 | 2,434,778 |
| 2018-08-14 | NOVARTIS AG | Open-market sale | 3,300 | $2.26 | 2,437,413 |
| 2018-08-14 | Novartis Bioventures Ltd | Open-market sale | 3,300 | $2.26 | 2,437,413 |
| 2018-08-13 | NOVARTIS AG | Open-market sale | 1,600 | $2.36 | 2,440,713 |
| 2018-08-13 | Novartis Bioventures Ltd | Open-market sale | 1,600 | $2.36 | 2,440,713 |
| 2018-08-10 | NOVARTIS AG | Open-market sale | 5,615 | $2.44 | 2,442,313 |
| 2018-08-10 | Novartis Bioventures Ltd | Open-market sale | 5,615 | $2.44 | 2,442,313 |
| 2018-08-09 | NOVARTIS AG | Open-market sale | 235 | $2.48 | 2,447,928 |
| 2018-08-09 | Novartis Bioventures Ltd | Open-market sale | 235 | $2.48 | 2,447,928 |
| 2018-08-08 | NOVARTIS AG | Open-market sale | 1,000 | $2.78 | 2,448,163 |
| 2018-08-08 | Novartis Bioventures Ltd | Open-market sale | 1,000 | $2.78 | 2,448,163 |
| 2018-08-07 | NOVARTIS AG | Open-market sale | 1,739 | $2.97 | 2,449,163 |
| 2018-08-07 | Novartis Bioventures Ltd | Open-market sale | 1,739 | $2.97 | 2,449,163 |
| 2018-08-06 | NOVARTIS AG | Open-market sale | 2,942 | $3.02 | 2,450,902 |
| 2018-08-06 | Novartis Bioventures Ltd | Open-market sale | 2,942 | $3.02 | 2,450,902 |
| 2018-08-02 | NOVARTIS AG | Open-market sale | 4,702 | $3.33 | 2,453,844 |
| 2018-08-02 | Novartis Bioventures Ltd | Open-market sale | 4,702 | $3.33 | 2,453,844 |
| 2018-08-01 | NOVARTIS AG | Open-market sale | 8,181 | $3.22 | 2,458,546 |
| 2018-08-01 | Novartis Bioventures Ltd | Open-market sale | 8,181 | $3.22 | 2,458,546 |
| 2018-07-31 | NOVARTIS AG | Open-market sale | 4,500 | $3.07 | 2,466,727 |
| 2018-07-31 | Novartis Bioventures Ltd | Open-market sale | 4,500 | $3.07 | 2,466,727 |
| 2018-07-30 | NOVARTIS AG | Open-market sale | 2,000 | $3.27 | 2,471,227 |
| 2018-07-30 | Novartis Bioventures Ltd | Open-market sale | 2,000 | $3.27 | 2,471,227 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.